Expression of CD44 in prostate cancer cells: Association with cell proliferation and invasive potential

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

High level expression of the cell surface adhesion molecule CD44 standard form and its splice variants, have been causally linked to tumor metastasis. In this study, we investigated the significance of CD44 expression in human prostatic carcinoma cells. Immunocytochemistry showed high level expression of CD44 in cells from a high grade prostate tumor, and two androgen-independent, invasive prostatic carcinoma lines, PC-3 and TSU-Pr1. Normal prostatic epithelial cells and LNCaP, a low metastatic, androgen sensitive cell line, expressed none to a very low level of CD44, although mRNA transcripts were detected in all cell lines. Immunoprecipitation detected two proteins of Mr ≃ 140 kDa and 210 kDa in PC-3, and predominantly the Mr ~ 95 kDa protein in TSU Pr1, but none in LNCaP. Most importantly, a neutralizing antibody to CD44 inhibited cell proliferation and basement membrane invasive activity suggesting a definitive role of CD44 in prostate tumor growth and metastasis.

Original languageEnglish (US)
Pages (from-to)1191-1198
Number of pages8
JournalAnticancer Research
Volume15
Issue number4
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Cell Proliferation
Androgens
Prostate
Neoplasm Metastasis
Carcinoma
Cell Line
Neoplasms
Cell Adhesion Molecules
Neutralizing Antibodies
Immunoprecipitation
Basement Membrane
Proteins
Epithelial Cells
Immunohistochemistry
Cell Membrane
Messenger RNA
Growth

Keywords

  • CD44
  • Cell adhesion molecules
  • Flow cytometry
  • Metastasis
  • Prostate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression of CD44 in prostate cancer cells : Association with cell proliferation and invasive potential. / Lokeshwar, Balakrishna L; Lokeshwar, Vinata B; Block, N. L.

In: Anticancer Research, Vol. 15, No. 4, 01.01.1995, p. 1191-1198.

Research output: Contribution to journalArticle

@article{e42f093730d244cfaf28dece4b78cd59,
title = "Expression of CD44 in prostate cancer cells: Association with cell proliferation and invasive potential",
abstract = "High level expression of the cell surface adhesion molecule CD44 standard form and its splice variants, have been causally linked to tumor metastasis. In this study, we investigated the significance of CD44 expression in human prostatic carcinoma cells. Immunocytochemistry showed high level expression of CD44 in cells from a high grade prostate tumor, and two androgen-independent, invasive prostatic carcinoma lines, PC-3 and TSU-Pr1. Normal prostatic epithelial cells and LNCaP, a low metastatic, androgen sensitive cell line, expressed none to a very low level of CD44, although mRNA transcripts were detected in all cell lines. Immunoprecipitation detected two proteins of Mr ≃ 140 kDa and 210 kDa in PC-3, and predominantly the Mr ~ 95 kDa protein in TSU Pr1, but none in LNCaP. Most importantly, a neutralizing antibody to CD44 inhibited cell proliferation and basement membrane invasive activity suggesting a definitive role of CD44 in prostate tumor growth and metastasis.",
keywords = "CD44, Cell adhesion molecules, Flow cytometry, Metastasis, Prostate cancer",
author = "Lokeshwar, {Balakrishna L} and Lokeshwar, {Vinata B} and Block, {N. L.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "15",
pages = "1191--1198",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - Expression of CD44 in prostate cancer cells

T2 - Association with cell proliferation and invasive potential

AU - Lokeshwar, Balakrishna L

AU - Lokeshwar, Vinata B

AU - Block, N. L.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - High level expression of the cell surface adhesion molecule CD44 standard form and its splice variants, have been causally linked to tumor metastasis. In this study, we investigated the significance of CD44 expression in human prostatic carcinoma cells. Immunocytochemistry showed high level expression of CD44 in cells from a high grade prostate tumor, and two androgen-independent, invasive prostatic carcinoma lines, PC-3 and TSU-Pr1. Normal prostatic epithelial cells and LNCaP, a low metastatic, androgen sensitive cell line, expressed none to a very low level of CD44, although mRNA transcripts were detected in all cell lines. Immunoprecipitation detected two proteins of Mr ≃ 140 kDa and 210 kDa in PC-3, and predominantly the Mr ~ 95 kDa protein in TSU Pr1, but none in LNCaP. Most importantly, a neutralizing antibody to CD44 inhibited cell proliferation and basement membrane invasive activity suggesting a definitive role of CD44 in prostate tumor growth and metastasis.

AB - High level expression of the cell surface adhesion molecule CD44 standard form and its splice variants, have been causally linked to tumor metastasis. In this study, we investigated the significance of CD44 expression in human prostatic carcinoma cells. Immunocytochemistry showed high level expression of CD44 in cells from a high grade prostate tumor, and two androgen-independent, invasive prostatic carcinoma lines, PC-3 and TSU-Pr1. Normal prostatic epithelial cells and LNCaP, a low metastatic, androgen sensitive cell line, expressed none to a very low level of CD44, although mRNA transcripts were detected in all cell lines. Immunoprecipitation detected two proteins of Mr ≃ 140 kDa and 210 kDa in PC-3, and predominantly the Mr ~ 95 kDa protein in TSU Pr1, but none in LNCaP. Most importantly, a neutralizing antibody to CD44 inhibited cell proliferation and basement membrane invasive activity suggesting a definitive role of CD44 in prostate tumor growth and metastasis.

KW - CD44

KW - Cell adhesion molecules

KW - Flow cytometry

KW - Metastasis

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0029092177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029092177&partnerID=8YFLogxK

M3 - Article

C2 - 7544562

AN - SCOPUS:0029092177

VL - 15

SP - 1191

EP - 1198

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -